TV Drug Ads: FDA May Pursue Further Research Before Policy Changes
Executive Summary
US agency's study found that mentioning fewer risks in direct-to-consumer ads helped with recall and in some cases with recognition but led viewers to say they didn’t have enough information.
You may also be interested in...
DTC Study Shows Limited Risk Statement Works, But Will Pharma Ad Practices Change?
Viewers retain more risks and benefits in DTC ads showing only limited risk information, but experts predict it may not result in substantial change right away.
Rx Advertising: Can Consumers And Doctors Tell When Drug Promos Are Deceptive?
US FDA to assess whether consumers and healthcare professionals can detect and report false or misleading promotions; Bad Ad program could be expanded to consumers.
DTC Trouble: ‘Attention-Grabbing Visuals’ Undermine Risk Info, FDA Tells Celgene, Sanofi
US agency is taking a stand against TV ads that present a drug’s serious risks as people are dancing to music or engaging in other compelling activities.